Management of Diabetes
Diabetes management requires immediate initiation of both lifestyle modifications and pharmacologic therapy at diagnosis, with metformin as the first-line medication for type 2 diabetes alongside comprehensive self-management education. 1, 2
Team-Based Care Structure
- Assemble a multidisciplinary team including physicians, nurses, dietitians, exercise specialists, pharmacists, and mental health professionals to manage all aspects of diabetes care 1, 3
- Implement the Chronic Care Model to ensure productive interactions between a prepared practice team and an informed, activated patient 1
- Use shared decision-making to improve treatment adherence, patient satisfaction, and clinical outcomes 3
Initial Evaluation Requirements
Perform a complete medical evaluation at diagnosis that includes:
- HbA1c, fasting glucose, lipid profile, kidney function tests, and urine albumin-to-creatinine ratio 3
- Classification of diabetes type and detection of existing complications 1, 3
- Screening for autoimmune conditions in type 1 diabetes (thyroid dysfunction, celiac disease) 1, 3
- Assessment for comorbidities: obesity, hypertension, dyslipidemia, and microvascular complications 1, 3
Glycemic Targets
- Set HbA1c goal of <7% for most adults, with more stringent targets (<6.5%) for selected individuals without significant hypoglycemia risk 2
- Individualize targets based on age, comorbidities, hypoglycemia risk, and life expectancy 1, 3, 2
- Monitor HbA1c every 3 months until target is reached, then at least twice yearly 2
Lifestyle Management
Medical Nutrition Therapy
- Provide individualized meal planning with no single ideal macronutrient distribution—tailor carbohydrate, protein, and fat percentages to individual assessment 4, 3, 2
- Recommend effective eating patterns including Mediterranean-style, DASH, plant-based, lower-fat, or lower-carbohydrate diets 1, 3
- Focus on nutrient-dense, high-quality foods while decreasing calorie-dense, nutrient-poor foods 2
- Reduce intake of saturated fat, trans fat, and cholesterol while increasing ω-3 fatty acids, viscous fiber, and plant stanols or sterols 1
Physical Activity
- Prescribe at least 150 minutes of moderate-intensity aerobic activity per week, spread across at least 5 days 1, 2
- Add resistance training at least twice weekly 1, 2
- Reduce sedentary time throughout the day 1, 2
Weight Management
- For overweight/obese patients, prescribe high-intensity diet, physical activity, and behavioral therapy designed to achieve ≥5% weight loss 1, 3, 2
- Implement a 500-750 kcal/day energy deficit to promote weight loss 1, 3
- Recognize that modest weight loss (5-7% of starting weight) provides clinical benefits including improved glycemia, blood pressure, and lipids 2
Pharmacologic Therapy for Type 2 Diabetes
First-Line Treatment
- Initiate metformin at diagnosis alongside lifestyle therapy if renal function is adequate 1, 3, 2
- Start metformin at a low dose and increase gradually to an ideal maximum dose of 2000 mg daily in divided doses 2
- Metformin is preferred due to its efficacy, safety, low cost, and potential cardiovascular benefits 2
Exceptions Requiring Insulin First
Initiate insulin instead of metformin as first-line treatment when patients present with:
- Ketosis or diabetic ketoacidosis 2
- Random blood glucose ≥250 mg/dL 2
- HbA1c >8.5% 2
- Symptomatic diabetes with polyuria, polydipsia, and weight loss 2
Treatment Intensification
- Add a second agent when metformin at maximum tolerated dose fails to achieve or maintain HbA1c target over 3 months 1, 2
- Second-line options include SGLT-2 inhibitors, GLP-1 receptor agonists, thiazolidinediones, DPP-4 inhibitors, or basal insulin 2
- Consider patient factors when selecting medications: efficacy, cost, side effects, weight effects, comorbidities, and hypoglycemia risk 1
Pharmacologic Therapy for Type 1 Diabetes
- Treat most patients with multiple-dose insulin injections (≥3 injections per day) or continuous subcutaneous insulin infusion 1, 2
- Use insulin analogues to reduce hypoglycemia risk 1, 2
- Educate patients on matching prandial insulin doses to carbohydrate intake, preprandial blood glucose levels, and anticipated activity level 1, 2
- Consider continuous glucose monitoring systems to significantly reduce severe hypoglycemia risk 2
Diabetes Self-Management Education and Support (DSMES)
- Provide DSMES to all patients at diagnosis and at critical points throughout their care 1, 3, 2
- Focus education on helping patients make informed self-management choices rather than simply providing information 1, 3
- Include essential content on hypoglycemia/hyperglycemia recognition and treatment, medication administration, blood glucose monitoring, and nutritional management 1, 3
- Use a patient-centered communication style that incorporates patient preferences, assesses literacy and numeracy, and addresses cultural barriers 1
Cardiovascular Risk Factor Management
Blood Pressure Control
- Target blood pressure <140/90 mmHg for most patients with diabetes 1, 3
- Implement lifestyle therapy consisting of weight loss, reduced-sodium diet, moderate alcohol intake, and increased physical activity 1
- Initiate pharmacologic therapy with either an ACE inhibitor or ARB (but not both) for confirmed hypertension 1, 2
Lipid Management
- Prescribe statin therapy for most persons with diabetes aged 40 years or older 1
- Recommend lifestyle modification to improve the lipid profile 1
- Base statin intensity on the patient's risk profile in addition to intensive lifestyle therapy 1
Hypoglycemia Management
- Reverse hypoglycemia (plasma glucose <3.9 mmol/L) with 15-20g of rapid-acting glucose 1, 2
- Confirm blood glucose after 15 minutes and repeat treatment if hypoglycemia persists 2
- Educate patients about situations that increase hypoglycemia risk: fasting for tests or procedures, during or after exercise, and during sleep 1, 2
- Increase glycemic targets temporarily in patients with hypoglycemia unawareness to partially reverse this condition 2
- Modify treatment regimens for severe or frequent hypoglycemia 2
Complication Screening and Prevention
- Conduct annual comprehensive eye examination 1, 3
- Screen for diabetic kidney disease annually 1, 3
- Perform comprehensive foot examination regularly 1, 3
- Screen for and treat modifiable cardiovascular risk factors 1, 3
- Provide all age-appropriate vaccinations 1, 3
Critical Pitfalls to Avoid
- Never share insulin pens or needles between patients—this poses a risk for transmission of blood-borne pathogens 5
- Always instruct patients to check the insulin label before each injection to avoid medication errors between insulin products 5
- Avoid aggressively targeting near-normal HbA1c levels in patients with advanced disease where such targets cannot be safely reached 2
- Monitor for lipodystrophy or localized cutaneous amyloidosis at injection sites—repeated injections into these areas cause hyperglycemia, and sudden site changes can cause hypoglycemia 5
- Observe patients treated with insulin and PPAR-gamma agonists (thiazolidinediones) for signs of heart failure due to dose-related fluid retention 5
- Monitor potassium levels in at-risk patients, as all insulins can cause hypokalemia leading to respiratory paralysis, ventricular arrhythmia, and death 5